Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and clinical concepts without systematic review methodology.
PubMed 42231717 · doi:10.1080/07853890.2026.2671594
What was done
This narrative review synthesized literature on the relationship between circadian rhythm disruption and major depressive disorder (MDD). The authors summarized mechanistic and clinical findings spanning clock gene genetics, neuroendocrine dysregulation (such as hypothalamic-pituitary-adrenal axis function and melatonin signaling), and chronotherapeutic approaches including light therapy, sleep interventions, and targeted pharmacotherapies.
What was found
The abstract reports no numerical findings, effect sizes, or quantitative trial outcomes. It qualitatively describes associations between MDD susceptibility and variants in core clock genes (CLOCK, TIMELESS, CRY1) alongside disruptions in sleep-wake cycles, diurnal mood patterns, and metabolic functions, suggesting circadian disruption plays a mechanistic role in MDD.
Why it matters
The paper frames circadian dysregulation as a potential causal contributor to depression rather than merely a downstream symptom, supporting the development of biomarker-guided chronotherapeutics.
Limits
This is a narrative review with no primary empirical data, systematic search methodology, or risk-of-bias assessment reported. The abstract provides no quantitative metrics to evaluate the clinical efficacy of specific chronotherapies.
Cited by
- context Waking up before dawn and being conscious and awake while the sun rises leads to increased productivity, creativity, focus, and happiness through neurochemical mechanisms.